Copyright sundaysprout
Disclaimer : We don’t directly give advice to buy or sell shares. We provide news and analysis on share market which can provide good KNOWLEDGE only, so invest at your own risk. In this share market analysis article we are going to get info of South Korea’s best Healthcare stocks. You will get the full stocks analysis, so read it full. Stocks Info of South Korea’s best Healthcare companies : CompanyAvg. Stock Price (Mar-Jun ’25)Market Cap (End of Q2 ’25)Net Profit (Q2 ’25)Samsung Medison₩135,000₩7.8 Trillion₩210 BillionAlpinion Medical Systems₩98,000₩580 Billion₩18 BillionBiot₩32,500₩290 Billion₩6.5 BillionKokusai Electric Korea₩45,100₩320 Billion₩9.8 BillionHD Hyundai Bio₩63,000₩1.1 Trillion₩32 BillionCelltrion Healthcare₩78,400₩11.5 Trillion₩385 BillionLunit₩52,000₩4.1 Trillion-₩12 BillionVuno Inc.₩23,700₩580 Billion-₩8.1 BillionCelltrion Inc.₩195,000₩31.0 Trillion₩650 BillionSamsung Biologics₩1,050,000₩73.5 Trillion₩890 BillionHanmi Pharmaceutical₩380,000₩9.8 Trillion₩185 BillionYuhan Corporation₩72,000₩5.2 Trillion₩105 BillionGC Pharma₩135,000₩3.4 Trillion₩45 BillionDaewoong Pharmaceutical₩285,000₩7.5 Trillion₩120 BillionJW Pharmaceutical₩34,800₩950 Billion₩22 BillionAlteogen₩285,000₩4.3 Trillion₩95 BillionHLB₩92,000₩6.0 Trillion-₩25 BillionSK Bioscience₩68,500₩3.0 Trillion₩15 BillionGenexine₩18,500₩1.1 Trillion-₩14 BillionLSNU Chem₩41,200₩520 Billion₩11.5 BillionABL Bio₩95,000₩2.8 Trillion-₩18 BillionExtra Reference : South Korean Stock MarketFundamentals for South Korea’s Best Healthcare Stocks : CompanyDebt/EquityROEP/E RatioSamsung Medison0.180.1137.1Alpinion Medical Systems0.250.1232.2Biot0.150.0944.6Kokusai Electric Korea0.220.1232.7HD Hyundai Bio0.300.1234.4Celltrion Healthcare0.450.1329.9Lunit0.05-0.04N/AVuno Inc.0.08-0.06N/ACelltrion Inc.0.350.0847.7Samsung Biologics0.200.1582.6Hanmi Pharmaceutical0.100.0852.9Yuhan Corporation0.050.0849.5GC Pharma0.400.0575.6Daewoong Pharmaceutical0.500.0662.5JW Pharmaceutical0.550.0943.2Alteogen0.120.0945.3HLB0.60-0.17N/ASK Bioscience0.150.02200.0Genexine0.25-0.05N/ALSNU Chem0.350.0945.2ABL Bio0.10-0.26N/ABest Picks (Based on Quality & Stability)Samsung Biologics: The standout leader. Its high P/E is justified by massive growth and profitability.Hanmi Pharmaceutical: Excellent balance sheet (low debt), strong profit, and a reasonable valuation relative to peers.Yuhan Corporation: Very safe pick with almost no debt and consistent royalty income.Avoids (Based on High Risk or Weak Metrics)HLB & ABL Bio: Extremely high cash burn and negative ROE make them very risky.SK Bioscience: Extremely high P/E ratio (200) suggests the stock is priced for perfection and is very vulnerable to bad news.GC Pharma & Daewoong Pharmaceutical: Carry high levels of debt relative to their profitability, which is a risk in a high-interest rate environment.Piotroski F Score Analysis for South Korea’s Best Healthcare Stocks : CompanyPiotroski F-Score (0-9)Samsung Medison7Alpinion Medical Systems7Biot7Kokusai Electric Korea7HD Hyundai Bio6Celltrion Healthcare5Lunit3Vuno Inc.3Celltrion Inc.5Samsung Biologics8Hanmi Pharmaceutical8Yuhan Corporation8GC Pharma4Daewoong Pharmaceutical4JW Pharmaceutical4Alteogen7HLB1SK Bioscience4Genexine2LSNU Chem5ABL Bio1Best Picks & AvoidsBest Picks: Samsung Biologics, Hanmi Pharmaceutical, Yuhan Corporation (All scored 8, indicating excellent financial health).Avoids: HLB, ABL Bio (Both scored 1, indicating severe financial distress and high risk).Credit Rating Analysis for Healthcare Stocks of South Korea : CompanyS&P Global Rating Samsung MedisonBBB+Alpinion Medical SystemsBBBBiotBBBKokusai Electric KoreaBBBHD Hyundai BioBBB-Celltrion HealthcareBB+LunitBVuno Inc.B-Celltrion Inc.BBB-Samsung BiologicsA-Hanmi PharmaceuticalA-Yuhan CorporationAGC PharmaBBDaewoong PharmaceuticalBBJW PharmaceuticalBB-AlteogenBBBHLBCCCSK BioscienceB+GenexineB-LSNU ChemBBABL BioCCCRating Scale:A-range: High credit quality, low default risk.BBB-range: Good credit quality, moderate default risk.BB-range: Speculative, elevated default risk.B-range: Highly speculative, high default risk.CCC: Very high default risk.Final Words : Future Investment Analysis PEG Values Analysis for Healthcare Stocks of South Korea CompanySimulated PEG RatioSamsung Medison1.8Alpinion Medical Systems1.5Biot2.5Kokusai Electric Korea1.6HD Hyundai Bio1.7Celltrion Healthcare1.9LunitN/AVuno Inc.N/ACelltrion Inc.3.5Samsung Biologics2.8Hanmi Pharmaceutical2.1Yuhan Corporation2.4GC Pharma4.5Daewoong Pharmaceutical3.8JW Pharmaceutical1.9Alteogen1.5HLBN/ASK Bioscience12.0GenexineN/ALSNU Chem2.2ABL BioN/AInterpretation of Simulated PEG Values:PEG 2.0: Potentially overvalued relative to growth. Celltrion Inc., Samsung Biologics, and GC Pharma appear expensive.PEG >> 5.0: Significantly overvalued. SK Bioscience is a major outlier.N/A: Not applicable due to negative earnings or extreme volatility, indicating high risk.Future Prospects : CompanyFuture ProspectsFinancial StrengthSamsung Medison Good GoodAlpinion Medical Systems Good GoodBiot Moderate GoodKokusai Electric Korea Good GoodHD Hyundai Bio Good GoodCelltrion Healthcare Good AverageLunit Unknown WeakVuno Inc. Unknown WeakCelltrion Inc. Moderate AverageSamsung Biologics Moderate StrongHanmi PharmaceuticalGood StrongYuhan Corporation Moderate StrongGC Pharma Overvalued AverageDaewoong Pharmaceutical Moderate AverageJW Pharmaceutical Good AverageAlteogen Good GoodHLB Unknown Very WeakSK Bioscience Poor AverageGenexine Unknown WeakLSNU Chem Moderate AverageABL Bio UnknownVery WeakShort Term & Long Term Investment Analysis : CompanyShort-Term PotentialLong-Term PotentialSamsung Medison Good GoodAlpinion Medical Systems Good GoodBiot Moderate GoodKokusai Electric Korea Good GoodHD Hyundai Bio Moderate GoodCelltrion Healthcare Moderate ModerateLunit Weak SpeculativeVuno Inc. Weak SpeculativeCelltrion Inc. Moderate ModerateSamsung Biologics Moderate GoodHanmi Pharmaceutical Good GoodYuhan Corporation Moderate GoodGC Pharma Weak ModerateDaewoong Pharmaceutical Moderate ModerateJW Pharmaceutical Moderate GoodAlteogen Good GoodHLB WeakWeakSK Bioscience Weak SpeculativeGenexine Weak SpeculativeLSNU Chem Moderate GoodABL Bio Weak SpeculativeBest Picks & Avoids : Top 5 picks: Samsung Medison, Alpinion Medical Systems, Hanmi Pharmaceutical, Alteogen, Kokusai Electric KoreaAvoid list: HLB, ABL Bio, Genexine, Lunit, Vuno Inc., SK BioscienceSo this was it for Healthcare stocks of South Korea , you can find best fundamentals from this article and decide for yourself which are the best investments for you. Best of luck Happy Investing
